Why eye movements
Exam of the eye movements tells more than a kilometer walk
Eye movements help predict disease evolution up to 5 years
scientific papers link eye-tracking with disorders
An easy-to-use eye-tracking environment
to help practitioners instantaneously quantify their clinical exam
Based on years of research, it is designed to bring non-invasive, quick, and robust biomarkers.
neuroClues® has the ambition to provide:
neuroClues® is a registered brand of P3Lab, currently under research and development phase. It will be available for sale when regulatory clearance is received.
Our scientific advisory board testifies
Over the last 60 years, over 110 000 scientific articles have been written linking eye movement to neurological diseases
Eye-tracking enables measurements and analysis, allowing neurologists to increase their diagnosis certainty in few minutes and have a better follow-up of the patients. This innovative technology can be used for the diagnosis of Parkinson’s disease and other neurological diseases.
Clinical highlights: update on Parkinson’s Disease
The newsletter of this month will emphasize the latest research about Parkinson’s disease (PD) as April is Parkinson’s Awareness month
Clinical highlights: Alzheimer’s disease
The newsletter of this month is related to the relevance of eye tracking in Alzheimer’s disease
NeuroClues™ (P3Lab) awarded funding from the European Commission through the prestigious EIC Accelerator Program
In summary P3Lab is one of the 78 companies selected among 1092 applicants by the European program EIC Accelerator. The funds will enable the company
Clinical highlights: eye tracking and concussion
The newsletter of this month is related to the relevance of eye tracking in Concussion